Intuitive Corp (ISRG): Earnings per share for the last twelve months
Growing global demand for robotic surgery opens immense prospects for Intuitive Surgical (ISRG). The business model relies on system sales and high-margin consumables. A team of top engineers ensures technological leadership. The history of rolling per-unit profit confirms the strategy's effectiveness, where the 8.26 mark serves as a current indicator, illustrating the company's ability to generate stable equity income.
Analytical breakdowns for Intuitive Surgical, Inc. (ISRG)
- stock price and consensus target price:
- stock exchange capitalization data:
- shareholders' equity book value data:
- debt burden and liquidity indicators:
Debt to Equity Intuitive Surgical|ISRG - Long-Term Debt to Capital Coefficient|Short-Term Debt to Equity Ratio Intuitive Surgical Inc|ISRG - Company Aggregate Debts|Debt to Book Capitalization Ratio Intuitive|ISRG - Company Long-Term Liabilities|Company Short-Term Debts Intuitive Surgical|Quick Liquidity intuitive.com
- earnings and multiples data:
ISRG - Company Profit|Future Profit Intuitive Surgical|ISRG - Market Price to Net Income Ratio|Future Price to Earnings Intuitive|ISRG - Growth-Adjusted Market Cap to Net Income|EV/EBITDA Multiple Intuitive|ISRG - Operating income before deduction of amortization|Earnings per share for the last twelve months Intuitive Surgical|ISRG - Earnings per share for the last 12 months|Year-over-year net earnings per share growth for the last 12 months intuitive.com|ISRG - Net earnings per one share growth for the current year|Expected earnings per share growth for next year Intuitive Surgical
Analysis of all company metrics:ISRG - Intuitive Surgical
Intuitive Surgical (ISRG) prioritizes the precision of robotic systems over the environmental agenda, creating a stable cash flow that reflects the 12-month rolling income per share. This metric measures the actual efficiency of profit generation per share regardless of issuance factors, allowing investors to differentiate the business's fundamental stability from market noise and determine the risk of overpaying at peak values.
Competitor analysis
Danaher Corp. - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters bd.com BDX|STERIS (STE) - Earnings per share for the last twelve months|Earnings per share for the last 12 months WST|Earnings per share for the last twelve months Baxter Corp|Masimo Inc. (MASI) - Net earnings per share for the last four quarters|Net earnings per share for the last 12 months STVN (Stevanato Group S.p.A.)|Earnings per share for the last four quarters TFX|Earnings per share for the last twelve months Merit Medical MMSI|Earnings per share for the trailing year NVST|ICUI: Net earnings per share for the last 12 months|XRAY - Net earnings per share (EPS TTM)|LeMaitre Vascular, Inc. (LMAT) - Earnings per share for the last twelve months|Net earnings per share for the last 12 months atricure.com|STAA (STAAR Surgical) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months ChromaDex Corp NAGE|Earnings per share for the last twelve months ZimVie Dental (ZIMV)|AngioDynamics Inc. - Earnings per share for the last 12 months|Cerus Corporation - Net earnings per share for the last 12 months|Earnings per share for the last four quarters TKNO (teknova.com)|MGRM - Earnings per share for the last twelve months|Net earnings per share for the last four quarters Sharps Technology, Inc. STSS|INFU: Net earnings per share (EPS TTM)|UTMD - Net earnings per share for the last four quarters|Earnings per share for the last twelve months KORU Medical Systems, Inc.|Earnings per share for the last 12 months NYXH (nyxoah.com)|Net earnings per share for the last 12 months MBOT (Microbot Medical)|Earnings per share for the last four quarters PDEX|Zentek Limited - Net earnings per share for the last 12 months|Net earnings per share (EPS TTM) Elutia Corporation ELUT|Milestone Scientific - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters nexgel.com NXGL|RVP (retractable.com) - Net earnings per share for the last 12 months|HBIO: Earnings per share for the last four quarters|FEMY (Femasys Corp) - Net earnings per share (EPS TTM)|Meihua Medical (MHUA) - Net earnings per share for the last four quarters|Net earnings per share for the last 12 months POAI (Predictive Oncology)|Earnings per share for the last twelve months CJMB (callanjmb.com)|Net earnings per share (EPS TTM) ATRI (Atrion)|NeuroMetrix Inc (NURO) - Net earnings per one share for the last twelve months
